Here, we demonstrate that IGF2BP1 promotes proliferation of neuroendocrine cancer cells by regulating the histone-lysine N-methyltransferase Enhancer of Zeste homolog 2 (EZH2) at the post-transcriptional level. This evidence concerns the gene IGF2BP1 and neuroendocrine carcinoma.